73 related articles for article (PubMed ID: 26548770)
1. Analysis of microRNA and gene networks in human chronic myelogenous leukemia.
Wang K; Xu Z; Wang N; Tian Y; Sun X; Ma Y
Mol Med Rep; 2016 Jan; 13(1):453-60. PubMed ID: 26548770
[TBL] [Abstract][Full Text] [Related]
2. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Fallah P; Amirizadeh N; Poopak B; Toogeh G; Arefian E; Kohram F; Hosseini Rad SM; Kohram M; Teimori Naghadeh H; Soleimani M
Int J Lab Hematol; 2015 Aug; 37(4):560-8. PubMed ID: 25833191
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the cross-talking of human competitive endogenous RNAs in K562 chronic myelogenous leukemia cell line.
Sen K; Sarkar A; Maji RK; Ghosh Z; Gupta S; Ghosh TC
Mol Biosyst; 2016 Nov; 12(12):3633-3642. PubMed ID: 27730241
[TBL] [Abstract][Full Text] [Related]
4. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of microRNAs associated with CML phases and their disease related targets.
Machová Poláková K; Lopotová T; Klamová H; Burda P; Trněný M; Stopka T; Moravcová J
Mol Cancer; 2011 Apr; 10():41. PubMed ID: 21501493
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?
Lopotová T; Záčková M; Klamová H; Moravcová J
Leuk Res; 2011 Jul; 35(7):974-7. PubMed ID: 21511335
[TBL] [Abstract][Full Text] [Related]
8. Novel structural co-expression analysis linking the NPM1-associated ribosomal biogenesis network to chronic myelogenous leukemia.
Chan LW; Lin X; Yung G; Lui T; Chiu YM; Wang F; Tsui NB; Cho WC; Yip SP; Siu PM; Wong SC; Yung BY
Sci Rep; 2015 Jul; 5():10973. PubMed ID: 26205693
[TBL] [Abstract][Full Text] [Related]
9. A Systems Biology-Based Approach to Uncovering Molecular Mechanisms Underlying Effects of Traditional Chinese Medicine Qingdai in Chronic Myelogenous Leukemia, Involving Integration of Network Pharmacology and Molecular Docking Technology.
Zhou C; Liu L; Zhuang J; Wei J; Zhang T; Gao C; Liu C; Li H; Si H; Sun C
Med Sci Monit; 2018 Jun; 24():4305-4316. PubMed ID: 29934492
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients.
Joshi D; Chandrakala S; Korgaonkar S; Ghosh K; Vundinti BR
Gene; 2014 Jun; 542(2):109-12. PubMed ID: 24680705
[TBL] [Abstract][Full Text] [Related]
11. Integrated computational biology analysis to evaluate target genes for chronic myelogenous leukemia.
Zheng Y; Wang YP; Cao H; Chen Q; Zhang X
Mol Med Rep; 2018 Aug; 18(2):1766-1772. PubMed ID: 29901125
[TBL] [Abstract][Full Text] [Related]
12. An Integrative Analysis of microRNA and mRNA Profiling in CML Stem Cells.
Nassar FJ; El Eit R; Nasr R
Methods Mol Biol; 2016; 1465():219-41. PubMed ID: 27581151
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations.
Xu L; Lu Y; Lai J; Yu W; Zhang Y; Jin Z; Xu Y; Chen J; Zha X; Chen S; Yang L; Li Y
Sci China Life Sci; 2015 Dec; 58(12):1276-81. PubMed ID: 26423566
[TBL] [Abstract][Full Text] [Related]
14. Noncoding RNAs and their functional involvement in regulation of chronic myeloid leukemia.
Wang X; Chen K; Guo G; Chen JL
Brief Funct Genomics; 2016 May; 15(3):239-48. PubMed ID: 26647283
[TBL] [Abstract][Full Text] [Related]
15. BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.
Sharma N; Magistroni V; Piazza R; Citterio S; Mezzatesta C; Khandelwal P; Pirola A; Gambacorti-Passerini C
Mol Cancer; 2015 Jul; 14():132. PubMed ID: 26179066
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
Agirre X; Jiménez-Velasco A; San José-Enériz E; Garate L; Bandrés E; Cordeu L; Aparicio O; Saez B; Navarro G; Vilas-Zornoza A; Pérez-Roger I; García-Foncillas J; Torres A; Heiniger A; Calasanz MJ; Fortes P; Román-Gómez J; Prósper F
Mol Cancer Res; 2008 Dec; 6(12):1830-40. PubMed ID: 19074828
[TBL] [Abstract][Full Text] [Related]
17. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
18. Chronic myelogenous leukemia molecular signature.
Nowicki MO; Pawlowski P; Fischer T; Hess G; Pawlowski T; Skorski T
Oncogene; 2003 Jun; 22(25):3952-63. PubMed ID: 12813469
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
Wu HK; Minden MD
Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
[TBL] [Abstract][Full Text] [Related]
20. [Progress of study on microRNA and chronic myeloid leukemia].
Liu H; Liu Y; Liu QF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):192-5. PubMed ID: 22391195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
